Tower Research Capital (TRC)’s Cocrystal Pharma COCP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.46K | Buy |
3,663
+1,706
| +87% | +$2.54K | ﹤0.01% | 4187 |
|
|
2025
Q1 | $2.78K | Buy |
1,957
+1,127
| +136% | +$1.6K | ﹤0.01% | 4509 |
|
|
2024
Q4 | $1.68K | Sell |
830
-1,913
| -70% | -$3.87K | ﹤0.01% | 4983 |
|
|
2024
Q3 | $4.83K | Sell |
2,743
-938
| -25% | -$1.65K | ﹤0.01% | 4407 |
|
|
2024
Q2 | $8.58K | Sell |
3,681
-3,775
| -51% | -$8.8K | ﹤0.01% | 4332 |
|
|
2024
Q1 | $10.4K | Buy |
7,456
+1,612
| +28% | +$2.26K | ﹤0.01% | 3696 |
|
|
2023
Q4 | $10.1K | Buy |
5,844
+2,496
| +75% | +$4.3K | ﹤0.01% | 4302 |
|
|
2023
Q3 | $6.26K | Sell |
3,348
-2,265
| -40% | -$4.24K | ﹤0.01% | 4627 |
|
|
2023
Q2 | $13.4K | Sell |
5,613
-3,038
| -35% | -$7.26K | ﹤0.01% | 3750 |
|
|
2023
Q1 | $17K | Buy |
8,651
+3,804
| +78% | +$7.48K | ﹤0.01% | 3621 |
|
|
2022
Q4 | $10K | Buy |
4,847
+2,124
| +78% | +$4.38K | ﹤0.01% | 3968 |
|
|
2022
Q3 | $10K | Buy |
2,723
+577
| +27% | +$2.12K | ﹤0.01% | 4517 |
|
|
2022
Q2 | $11K | Buy |
2,146
+1,445
| +206% | +$7.41K | ﹤0.01% | 4361 |
|
|
2022
Q1 | $5K | Buy |
+701
| New | +$5K | ﹤0.01% | 5032 |
|
|
2020
Q4 | – | Sell |
-941
| Closed | -$11K | – | 5149 |
|
|
2020
Q3 | $11K | Buy |
941
+220
| +31% | +$2.57K | ﹤0.01% | 4055 |
|
|
2020
Q2 | $13K | Buy |
+721
| New | +$13K | ﹤0.01% | 3892 |
|
|
2019
Q3 | – | Sell |
-8
| Closed | – | – | 4135 |
|
|
2019
Q2 | $0 | Sell |
8
-118
| -94% | – | ﹤0.01% | 3751 |
|
|
2019
Q1 | $4K | Buy |
+126
| New | +$4K | ﹤0.01% | 3143 |
|
|
2018
Q4 | – | Sell |
-163
| Closed | -$5K | – | 3869 |
|
|
2018
Q3 | $5K | Buy |
+163
| New | +$5K | ﹤0.01% | 3103 |
|